Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

214.6300 USD 3.2600 1.50%

As of 20:04:04 ET on 02/27/2015.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 216.8900 High - Low: 217.6270 - 212.9000 Primary Exchange: NYSE Arca
Volume: 916,125 52-Week Range: 115.3117 - 219.1100 Beta vs SPSIBITR: 0.9991

ETF Chart for XBI

No chart data available.
  • XBI:US 214.6300
  • 1D
  • 1M
  • 1Y
217.8900
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2015-02-27) 214.5708
Assets (M) (on 2015-02-27) 2,102.7940
Shares out (M) 9.80
Market Cap (M) 2,103.37
% Premium 0.03
Average 52-Week % Premium -0.0026
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-19) 0.4910
Dividend Yield (ttm) 0.93%

Performance for XBI

1-Month +7.50% 1-Year +32.72%
3-Month +19.67% 3-Year +41.64%
Year To Date +15.11% 5-Year +31.07%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 02/27/2015
Name Position Value % of Total
Exelixis Inc 15,603,485 45,718,211 2.175%
Foundation Medicine Inc 930,663 44,448,465 2.115%
Halozyme Therapeutics Inc 2,733,997 41,201,335 1.960%
OPKO Health Inc 2,670,545 38,883,135 1.850%
Neurocrine Biosciences Inc 994,312 38,827,884 1.847%
Pharmacyclics Inc 164,667 35,556,545 1.692%
Intercept Pharmaceuticals Inc 158,694 35,130,091 1.671%
Novavax Inc 3,792,525 34,701,604 1.651%
Intrexon Corp 808,710 33,205,633 1.580%
TESARO Inc 584,985 31,197,250 1.484%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil